Boston Scientific Corp

Company Profile

Boston Scientific Corp had its IPO on 1992-05-19 under the ticker symbol BSX.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Boston Scientific Corp has a staff strength of 0 employees.

Stock update

Shares of Boston Scientific Corp opened at $42.53 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $41.92 - $43.73, and closed at $41.93.

This is a -1.94% slip from the previous day's closing price.

A total volume of 12,423,964 shares were traded at the close of the day’s session.

In the last one week, shares of Boston Scientific Corp have increased by +2.27%.

Boston Scientific Corp's Key Ratios

Boston Scientific Corp has a market cap of $60.027 billion, indicating a price to book ratio of 3.548 and a price to sales ratio of 4.777.

In the last 12-months Boston Scientific Corp’s revenue was $12.567 billion with a gross profit of $8.241 billion and an EBITDA of $3.343 billion. The EBITDA ratio measures Boston Scientific Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Boston Scientific Corp’s operating margin was 17.5% while its return on assets stood at 4.19% with a return of equity of 0%.

In Q3, Boston Scientific Corp’s quarterly earnings growth was a negative -57.1% while revenue growth was a positive 8.1%.

Boston Scientific Corp’s PE and PEG Ratio

Forward PE

21.98

Trailing PE

102.27

PEG

2.294

Its diluted EPS in the last 12-months stands at $0.41 per share while it has a forward price to earnings multiple of 21.98 and a PEG multiple of 2.294. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Boston Scientific Corp’s profitability.

Boston Scientific Corp stock is trading at a EV to sales ratio of 5.59 and a EV to EBITDA ratio of 32.64. Its price to sales ratio in the trailing 12-months stood at 4.777.

Boston Scientific Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Boston Scientific Corp ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Boston Scientific Corp ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Boston Scientific Corp’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Boston Scientific Corp's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Boston Scientific Corp paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$41.93

52-Week High

$47.5

52-Week Low

$34.98

Analyst Target Price

$48.95

Boston Scientific Corp stock is currently trading at $41.93 per share. It touched a 52-week high of $47.5 and a 52-week low of $47.5. Analysts tracking the stock have a 12-month average target price of $48.95.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.